America’s FDA leadership has been making decisions based on ideology, not drug safety.
Back in the early 2000s, the FDA launched the Safety First Steering Committee (SFSC). It was created to address the safety concerns of marketed drugs of noteworthy concern to Americans. Today, the acronym is still found ubiquitously throughout FDA documents, but links to its web page no longer function.
It appears to have been replaced by the Drug Risk Management Board (DRMB). The DRMB has no public-facing webpage, but it seems that the DRMB is a rebranded SFSC.
Per the FDA:
The DRMB is a cross-CDER governance board responsible for three key objectives: (1) facilitating and coordinating decisions around major product safety issues, (2) providing clear and consistent guidance enabling an appropriate response to major safety issues, and (3) systematically communicating decisions…
